IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v15y2024i1d10.1038_s41467-024-51909-2.html
   My bibliography  Save this article

XENTURION is a population-level multidimensional resource of xenografts and tumoroids from metastatic colorectal cancer patients

Author

Listed:
  • Simonetta M. Leto

    (Candiolo Cancer Institute – FPO IRCCS)

  • Elena Grassi

    (Candiolo Cancer Institute – FPO IRCCS
    University of Torino)

  • Marco Avolio

    (Candiolo Cancer Institute – FPO IRCCS
    University of Torino)

  • Valentina Vurchio

    (Candiolo Cancer Institute – FPO IRCCS
    University of Torino)

  • Francesca Cottino

    (Candiolo Cancer Institute – FPO IRCCS)

  • Martina Ferri

    (Candiolo Cancer Institute – FPO IRCCS
    University of Torino)

  • Eugenia R. Zanella

    (Candiolo Cancer Institute – FPO IRCCS)

  • Sofia Borgato

    (Candiolo Cancer Institute – FPO IRCCS
    University of Torino)

  • Giorgio Corti

    (University of Torino)

  • Laura Blasio

    (Candiolo Cancer Institute – FPO IRCCS
    University of Torino)

  • Desiana Somale

    (Candiolo Cancer Institute – FPO IRCCS
    an Evotec Company)

  • Marianela Vara-Messler

    (Candiolo Cancer Institute – FPO IRCCS
    University of Torino
    Sanofi Belgium)

  • Francesco Galimi

    (Candiolo Cancer Institute – FPO IRCCS
    University of Torino)

  • Francesco Sassi

    (Candiolo Cancer Institute – FPO IRCCS)

  • Barbara Lupo

    (Candiolo Cancer Institute – FPO IRCCS
    University of Torino)

  • Irene Catalano

    (Candiolo Cancer Institute – FPO IRCCS)

  • Marika Pinnelli

    (Candiolo Cancer Institute – FPO IRCCS
    University of Torino)

  • Marco Viviani

    (Candiolo Cancer Institute – FPO IRCCS
    University of Torino)

  • Luca Sperti

    (Candiolo Cancer Institute – FPO IRCCS
    University of Torino)

  • Alfredo Mellano

    (Candiolo Cancer Institute – FPO IRCCS)

  • Alessandro Ferrero

    (Mauriziano Umberto I Hospital)

  • Caterina C. Zingaretti

    (Mauriziano Umberto I Hospital)

  • Alberto Puliafito

    (Candiolo Cancer Institute – FPO IRCCS
    University of Torino)

  • Luca Primo

    (Candiolo Cancer Institute – FPO IRCCS
    University of Torino)

  • Andrea Bertotti

    (Candiolo Cancer Institute – FPO IRCCS
    University of Torino)

  • Livio Trusolino

    (Candiolo Cancer Institute – FPO IRCCS
    University of Torino)

Abstract

The breadth and depth at which cancer models are interrogated contribute to the successful clinical translation of drug discovery efforts. In colorectal cancer (CRC), model availability is limited by a dearth of large-scale collections of patient-derived xenografts (PDXs) and paired tumoroids from metastatic disease, where experimental therapies are typically tested. Here we introduce XENTURION, an open-science resource offering a platform of 128 PDX models from patients with metastatic CRC, along with matched PDX-derived tumoroids. Multidimensional omics analyses indicate that tumoroids retain extensive molecular fidelity with parental PDXs. A tumoroid-based trial with the anti-EGFR antibody cetuximab reveals variable sensitivities that are consistent with clinical response biomarkers, mirror tumor growth changes in matched PDXs, and recapitulate EGFR genetic deletion outcomes. Inhibition of adaptive signals upregulated by EGFR blockade increases the magnitude of cetuximab response. These findings illustrate the potential of large living biobanks, providing avenues for molecularly informed preclinical research in oncology.

Suggested Citation

  • Simonetta M. Leto & Elena Grassi & Marco Avolio & Valentina Vurchio & Francesca Cottino & Martina Ferri & Eugenia R. Zanella & Sofia Borgato & Giorgio Corti & Laura Blasio & Desiana Somale & Marianela, 2024. "XENTURION is a population-level multidimensional resource of xenografts and tumoroids from metastatic colorectal cancer patients," Nature Communications, Nature, vol. 15(1), pages 1-22, December.
  • Handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-51909-2
    DOI: 10.1038/s41467-024-51909-2
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-024-51909-2
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-024-51909-2?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Enzo Medico & Mariangela Russo & Gabriele Picco & Carlotta Cancelliere & Emanuele Valtorta & Giorgio Corti & Michela Buscarino & Claudio Isella & Simona Lamba & Barbara Martinoglio & Silvio Veronese &, 2015. "The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets," Nature Communications, Nature, vol. 6(1), pages 1-10, November.
    2. Daniela Bakula & Amelie J. Müller & Theresia Zuleger & Zsuzsanna Takacs & Mirita Franz-Wachtel & Ann-Katrin Thost & Daniel Brigger & Mario P. Tschan & Tancred Frickey & Horst Robenek & Boris Macek & T, 2017. "WIPI3 and WIPI4 β-propellers are scaffolds for LKB1-AMPK-TSC signalling circuits in the control of autophagy," Nature Communications, Nature, vol. 8(1), pages 1-18, August.
    3. Andrea Bertotti & Eniko Papp & Siân Jones & Vilmos Adleff & Valsamo Anagnostou & Barbara Lupo & Mark Sausen & Jillian Phallen & Carolyn A. Hruban & Collin Tokheim & Noushin Niknafs & Monica Nesselbush, 2015. "The genomic landscape of response to EGFR blockade in colorectal cancer," Nature, Nature, vol. 526(7572), pages 263-267, October.
    4. Fiona M. Behan & Francesco Iorio & Gabriele Picco & Emanuel Gonçalves & Charlotte M. Beaver & Giorgia Migliardi & Rita Santos & Yanhua Rao & Francesco Sassi & Marika Pinnelli & Rizwan Ansari & Sarah H, 2019. "Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens," Nature, Nature, vol. 568(7753), pages 511-516, April.
    5. Philip D. Dunne & Matthew Alderdice & Paul G. O'Reilly & Aideen C. Roddy & Amy M. B. McCorry & Susan Richman & Tim Maughan & Simon S. McDade & Patrick G. Johnston & Daniel B. Longley & Elaine Kay & Da, 2017. "Cancer-cell intrinsic gene expression signatures overcome intratumoural heterogeneity bias in colorectal cancer patient classification," Nature Communications, Nature, vol. 8(1), pages 1-12, August.
    6. James M. McFarland & Zandra V. Ho & Guillaume Kugener & Joshua M. Dempster & Phillip G. Montgomery & Jordan G. Bryan & John M. Krill-Burger & Thomas M. Green & Francisca Vazquez & Jesse S. Boehm & Tod, 2018. "Improved estimation of cancer dependencies from large-scale RNAi screens using model-based normalization and data integration," Nature Communications, Nature, vol. 9(1), pages 1-13, December.
    7. Jesse S. Boehm & Mathew J. Garnett & David J. Adams & Hayley E. Francies & Todd R. Golub & William C. Hahn & Francesco Iorio & James M. McFarland & Leopold Parts & Francisca Vazquez, 2021. "Cancer research needs a better map," Nature, Nature, vol. 589(7843), pages 514-516, January.
    8. Hua Sun & Song Cao & R. Jay Mashl & Chia-Kuei Mo & Simone Zaccaria & Michael C. Wendl & Sherri R. Davies & Matthew H. Bailey & Tina M. Primeau & Jeremy Hoog & Jacqueline L. Mudd & Dennis A. Dean & Raj, 2021. "Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidates for targeted treatment," Nature Communications, Nature, vol. 12(1), pages 1-20, December.
    9. Fran Supek & Matko Bošnjak & Nives Škunca & Tomislav Šmuc, 2011. "REVIGO Summarizes and Visualizes Long Lists of Gene Ontology Terms," PLOS ONE, Public Library of Science, vol. 6(7), pages 1-9, July.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Sanju Sinha & Karina Barbosa & Kuoyuan Cheng & Mark D. M. Leiserson & Prashant Jain & Anagha Deshpande & David M. Wilson & Bríd M. Ryan & Ji Luo & Ze’ev A. Ronai & Joo Sang Lee & Aniruddha J. Deshpand, 2021. "A systematic genome-wide mapping of oncogenic mutation selection during CRISPR-Cas9 genome editing," Nature Communications, Nature, vol. 12(1), pages 1-13, December.
    2. Ruitong Li & Olaf Klingbeil & Davide Monducci & Michael J. Young & Diego J. Rodriguez & Zaid Bayyat & Joshua M. Dempster & Devishi Kesar & Xiaoping Yang & Mahdi Zamanighomi & Christopher R. Vakoc & Ta, 2022. "Comparative optimization of combinatorial CRISPR screens," Nature Communications, Nature, vol. 13(1), pages 1-10, December.
    3. Miguel M. Álvarez & Josep Biayna & Fran Supek, 2022. "TP53-dependent toxicity of CRISPR/Cas9 cuts is differential across genomic loci and can confound genetic screening," Nature Communications, Nature, vol. 13(1), pages 1-14, December.
    4. Alexander Platzer & Thomas Nussbaumer & Thomas Karonitsch & Josef S Smolen & Daniel Aletaha, 2019. "Analysis of gene expression in rheumatoid arthritis and related conditions offers insights into sex-bias, gene biotypes and co-expression patterns," PLOS ONE, Public Library of Science, vol. 14(7), pages 1-23, July.
    5. Alexendar R. Perez & Laura Sala & Richard K. Perez & Joana A. Vidigal, 2021. "CSC software corrects off-target mediated gRNA depletion in CRISPR-Cas9 essentiality screens," Nature Communications, Nature, vol. 12(1), pages 1-11, December.
    6. Xuefeng Wang & Shuo Zhang & Yuqin liu, 2022. "ITGInsight–discovering and visualizing research fronts in the scientific literature," Scientometrics, Springer;Akadémiai Kiadó, vol. 127(11), pages 6509-6531, November.
    7. Rachel A. Steward & Maaike A. de Jong & Vicencio Oostra & Christopher W. Wheat, 2022. "Alternative splicing in seasonal plasticity and the potential for adaptation to environmental change," Nature Communications, Nature, vol. 13(1), pages 1-12, December.
    8. Sebastijan Hobor & Maise Al Bakir & Crispin T. Hiley & Marcin Skrzypski & Alexander M. Frankell & Bjorn Bakker & Thomas B. K. Watkins & Aleksandra Markovets & Jonathan R. Dry & Andrew P. Brown & Jaspe, 2024. "Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling," Nature Communications, Nature, vol. 15(1), pages 1-21, December.
    9. Arindam Datta & Kajal Biswas & Joshua A. Sommers & Haley Thompson & Sanket Awate & Claudia M. Nicolae & Tanay Thakar & George-Lucian Moldovan & Robert H. Shoemaker & Shyam K. Sharan & Robert M. Brosh, 2021. "WRN helicase safeguards deprotected replication forks in BRCA2-mutated cancer cells," Nature Communications, Nature, vol. 12(1), pages 1-22, December.
    10. Mathew Pette & Andrew Dimond & António M. Galvão & Steven J. Millership & Wilson To & Chiara Prodani & Gráinne McNamara & Ludovica Bruno & Alessandro Sardini & Zoe Webster & James McGinty & Paul M. W., 2022. "Epigenetic changes induced by in utero dietary challenge result in phenotypic variability in successive generations of mice," Nature Communications, Nature, vol. 13(1), pages 1-14, December.
    11. Fei Li & Yizhe Wang & Inah Hwang & Ja-Young Jang & Libo Xu & Zhong Deng & Eun Young Yu & Yiming Cai & Caizhi Wu & Zhenbo Han & Yu-Han Huang & Xiangao Huang & Ling Zhang & Jun Yao & Neal F. Lue & Paul , 2023. "Histone demethylase KDM2A is a selective vulnerability of cancers relying on alternative telomere maintenance," Nature Communications, Nature, vol. 14(1), pages 1-16, December.
    12. Sara Della Torre & Valeria Benedusi & Giovanna Pepe & Clara Meda & Nicoletta Rizzi & Nina Henriette Uhlenhaut & Adriana Maggi, 2021. "Dietary essential amino acids restore liver metabolism in ovariectomized mice via hepatic estrogen receptor α," Nature Communications, Nature, vol. 12(1), pages 1-13, December.
    13. Xiao Chen & Yinglu Li & Fang Zhu & Xinjing Xu & Brian Estrella & Manuel A. Pazos & John T. McGuire & Dimitris Karagiannis & Varun Sahu & Mustafo Mustafokulov & Claudio Scuoppo & Francisco J. Sánchez-R, 2023. "Context-defined cancer co-dependency mapping identifies a functional interplay between PRC2 and MLL-MEN1 complex in lymphoma," Nature Communications, Nature, vol. 14(1), pages 1-17, December.
    14. David R. Ghasemi & Konstantin Okonechnikov & Anne Rademacher & Stephan Tirier & Kendra K. Maass & Hanna Schumacher & Piyush Joshi & Maxwell P. Gold & Julia Sundheimer & Britta Statz & Ahmet S. Rifaiog, 2024. "Compartments in medulloblastoma with extensive nodularity are connected through differentiation along the granular precursor lineage," Nature Communications, Nature, vol. 15(1), pages 1-20, December.
    15. Dustin J. Flanagan & Raheleh Amirkhah & David F. Vincent & Nuray Gunduz & Pauline Gentaz & Patrizia Cammareri & Aoife J. McCooey & Amy M. B. McCorry & Natalie C. Fisher & Hayley L. Davis & Rachel A. R, 2022. "Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features," Nature Communications, Nature, vol. 13(1), pages 1-18, December.
    16. Logan Brase & Shih-Feng You & Ricardo D’Oliveira Albanus & Jorge L. Del-Aguila & Yaoyi Dai & Brenna C. Novotny & Carolina Soriano-Tarraga & Taitea Dykstra & Maria Victoria Fernandez & John P. Budde & , 2023. "Single-nucleus RNA-sequencing of autosomal dominant Alzheimer disease and risk variant carriers," Nature Communications, Nature, vol. 14(1), pages 1-19, December.
    17. Fabio Alfieri & Giulio Caravagna & Martin H. Schaefer, 2023. "Cancer genomes tolerate deleterious coding mutations through somatic copy number amplifications of wild-type regions," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    18. Hannah L. Mackay & Helen R. Stone & George E. Ronson & Katherine Ellis & Alexander Lanz & Yara Aghabi & Alexandra K. Walker & Katarzyna Starowicz & Alexander J. Garvin & Patrick Van Eijk & Stefan A. K, 2024. "USP50 suppresses alternative RecQ helicase use and deleterious DNA2 activity during replication," Nature Communications, Nature, vol. 15(1), pages 1-17, December.
    19. Richard Culliford & Samuel E. D. Lawrence & Charlie Mills & Zayd Tippu & Daniel Chubb & Alex J. Cornish & Lisa Browning & Ben Kinnersley & Robert Bentham & Amit Sud & Husayn Pallikonda & Anna Frangou , 2024. "Whole genome sequencing refines stratification and therapy of patients with clear cell renal cell carcinoma," Nature Communications, Nature, vol. 15(1), pages 1-14, December.
    20. Jennifer T. Wolstenholme & Justin M. Saunders & Maren Smith & Jason D. Kang & Phillip B. Hylemon & Javier González-Maeso & Andrew Fagan & Derrick Zhao & Masoumeh Sikaroodi & Jeremy Herzog & Amirhossei, 2022. "Reduced alcohol preference and intake after fecal transplant in patients with alcohol use disorder is transmissible to germ-free mice," Nature Communications, Nature, vol. 13(1), pages 1-14, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-51909-2. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.